Skip to main content

Table 1 Characteristics of the HIV-1-infected men followed longitudinally before and after initiation of antiretroviral treatment that are shown in Figures 3 and 4

From: HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells

PRE/POST Antiretroviral treatment

Number or Median (IQR)

Number of patients

16

Age (years)

36 (24–40)

Antiretroviral treatment regimen

 

Non-Nucleoside Reverse Transcriptase Inhibitors

8

Protease Inhibitors

7

Integrase Inhibitors

1

Time from diagnosis to antiretroviral treatment (months)

2 (1.5-5)

Time between samples (months)

11 (7–19)

CD4+ T-cell count (cells/μl)

 

PRE antiretroviral treatment

297 (239–316)

POST antiretroviral treatment

505 (401–597)

Plasma Viral Load (Log10 HIV RNA copies/ml)

 

PRE antiretroviral treatment

5 (4.4-5.5)

POST antiretroviral treatment

1.7 (1.4-1.7)